(As of 9/30/2024)

RBC Life Science and Technology Fund Series A

(U.S. Equity)
FundGrade A+® Rating recipient
For more information about FundGrade click here
2022
2021
2020
2015



Inception Return
(7/31/1995)
8.14 %
YTD Return 26.49 %
NAVPS
(10/22/2024)
$52.89
Change ($0.07) / -0.14 %
Growth of $10,000 (As of September 30, 2024)
MER 2.05 %
Assets ($mil) $2,129.97
Rank (1Yr) 200/1263
Std Dev (3Yr) 14.98 %
Volatility Ranking (3Yr) 9/10
RRSP Eligibility Yes
Load No Load
Max Front End -
Max Back End -
Sales Status Open
 
Objective
The objective of the fund is to provide long-term capital growth. The fund invests primarily in equity securities of U.S. companies whose businesses relate to life sciences and technology and are expected to benefit from scientific and technological advances.
Fund Manager

RBC Global Asset Management Inc.

Portfolio Manager

Rob Cavallo, RBC Global Asset Management Inc.

Marcello Montanari, RBC Global Asset Management Inc.

Sub-Advisor
Data not available
 
Asset Allocation
(As of August 31, 2024)
Sector Allocation
(As of August 31, 2024)
Geographic Allocation
(As of August 31, 2024)
Top 10 Holdings
NameAssetSectorGeographicPercent
NVIDIA CorpUS EquityTechnologyUnited States11.49%
Microsoft CorpUS EquityTechnologyUnited States9.53%
Apple IncUS EquityTechnologyUnited States8.82%
Alphabet Inc Cl AUS EquityTechnologyUnited States8.11%
Meta Platforms Inc Cl AUS EquityTechnologyUnited States4.97%
Eli Lilly and CoUS EquityHealthcareUnited States3.42%
Broadcom IncUS EquityTechnologyUnited States2.56%
UnitedHealth Group IncUS EquityHealthcareUnited States2.23%
Merck & Co IncUS EquityHealthcareUnited States1.57%
Adobe IncUS EquityTechnologyUnited States1.40%

Performance Data (As of September 30, 2024)
  Return (%) Annualized Return (%)
Return 1 Mth 3 Mth 6 Mth YTD 1 Yr 3 Yr 5 Yr 10 Yr
Fund 1.64 0.60 10.00 26.49 39.60 13.90 19.05 17.04
Benchmark 2.23 4.47 10.05 24.64 36.19 14.37 16.43 15.52
Quartile Ranking 3 4 1 1 1 1 1 1

Calendar Return (%) 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Fund 37.42 -22.89 24.97 29.23 25.94 8.77 22.08 -0.84 21.81 26.86
Benchmark 23.32 -12.52 28.16 16.07 25.18 3.98 13.80 8.65 20.77 24.19
Quartile Ranking 1 4 2 1 2 1 1 4 1 1

Website powered by © Fundata Canada Inc.
Mutual Fund Data provided by Fundata. | View Terms and Conditions of Use.
BofA Merill Lynch Indices used with permission.
© 2024 Fundata Canada Inc. All rights reserved. | View Privacy Policy | Contact Us.